Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
EXTON, PA — Innovative Aerosystems (Nasdaq: ISSC) recently entered into an asset purchase and perpetual license agreement with Honeywell International Inc. (Nasdaq: HON) to acquire aftermarket parts, intellectual property, and …
Innovative Aerosystems Acquires Honeywell Avionics Assets Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) will release its first-quarter 2026 financial results before markets open on Thursday, May 7, followed by a webcast hosted by senior management …
Bentley Systems Sets May 7 Date for First-Quarter Results Read More
MALVERN, PA — Pacer ETFs recently launched the Pacer ActiveAlpha India Quality ETF (Nasdaq: INDQ), a new fund designed to provide exposure to Indian equities using a factor-based investment approach.
Pacer Launches India-Focused ETF INDQ on Nasdaq Read More
MALVERN, PA — Ocugen Inc. (Nasdaq: OCGN) has completed enrollment and dosing in its Phase 2/3 clinical trial evaluating a gene therapy candidate for Stargardt disease.
Ocugen Completes Dosing in Stargardt Disease Gene Therapy Trial Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) recently reported its full-year 2025 financial results and outlined progress across its QTORIN drug development pipeline, including plans to submit a new …
Palvella Reports 2025 Results, Advances QTORIN Drug Pipeline Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the publication of a review article in the Journal of Vascular Anomalies examining clinical differences and treatment approaches for microcystic and …
Palvella Publishes Review on Lymphatic Malformations in Medical Journal Read More WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) recently appointed Jennifer J. McDonough as senior vice president of market access and patient services as the company prepares for a potential …
Palvella Appoints McDonough as SVP of Market Access, Patient Services Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS) will present new data from its Phase 2a trial of ATI-2138 in patients with moderate-to-severe atopic dermatitis at the 2026 American Academy …
Aclaris to Present Phase 2a ATI-2138 Data at Dermatology Meeting Read More WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) has completed patient enrollment in its Phase 2 trial of bosakitug in patients with moderate-to-severe atopic dermatitis, marking a development milestone for …
Aclaris Completes Enrollment in Phase 2 Trial of Bosakitug for Atopic Dermatitis Read More
MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) reported higher fourth-quarter and full-year 2025 revenue, narrowed its losses, posted positive operating cash flow in the fourth quarter, and said Dan Reuvers …
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook Read More